Removal of aprotinin from low-dose aprotinin/tranexamic acid antifibrinolytic therapy increases transfusion requirements in cardiothoracic surgery-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Removal of aprotinin from low-dose aprotinin/tranexamic acid antifibrinolytic therapy increases transfusion requirements in cardiothoracic surgery

Published:2011-02-01 Issue:2 Volume:12 Page:135-140
ISSN:1569-9293
Container-title:Interactive CardioVascular and Thoracic Surgery
language:en
Short-container-title:Interactive CardioVascular and Thoracic Surgery

Author:

Vonk A. B. A.,Meesters M. I.,Schats J.,Romijn J. W. A.,Jansen E. K.,Boer C.

Publisher

Oxford University Press (OUP)

Subject

Cardiology and Cardiovascular Medicine,Pulmonary and Respiratory Medicine,Surgery

Link

http://academic.oup.com/icvts/article-pdf/12/2/135/2217876/12-2-135.pdf

Reference14 articles.

1. Hemostatic efficacy of dipyridamole, tranexamic acid, and aprotinin in coronary bypass grafting

2. Reduction of Blood Loss and Transfusion Requirements After Coronary Artery Bypass Grafting:.

3. Tranexamic Acid and Aprotinin in Primary Cardiac Operations: An Analysis of 220 Cardiac Surgical Patients Treated with Tranexamic Acid or Aprotinin

4. Aprotinin in Cardiac Surgery: A Review of Conventional and Novel Mechanisms of Action

5. Mortality Associated With Aprotinin During 5 Years Following Coronary Artery Bypass Graft Surgery

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Comparison of intraoperative tranexamic acid and epsilon-aminocaproic acid in cardiopulmonary bypass patients;JTCVS Open;2020-09

2. Role of Blood Bank, Transfusion Services, and Pharmacy in ICU Patients with Hematologic Challenges;Hematologic Challenges in the Critically Ill;2018

3. Level of agreement between laboratory and point-of-care prothrombin time before and after cardiopulmonary bypass in cardiac surgery;Thrombosis Research;2014-06

4. The second Austrian benchmark study for blood use in elective surgery: results and practice change;Transfusion;2014-05-08

5. Ten-year patterns in blood product utilization during cardiothoracic surgery with cardiopulmonary bypass in a tertiary hospital;Transfusion;2013-12-23

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3